Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

Immunome, Inc. ("Immunome") (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class ...

Highlights:,Institutional investment managers have adjusted their positions in Veracyte (NASDAQ:VCYT).,The company registered ...

Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching ...

Anirvan Ghosh, the Chief Executive Officer of Unity Biotechnology, Inc. (NASDAQ:UBX), recently sold 642 shares of the company's common stock. The biotech company, currently valued at $38.42 million, ...

Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...

Jan. 13, 2025 — Girolline, a compound extracted from the sea sponge Pseudaxinyssa cantharella, has been investigated for possible antitumor effects and also found to ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its fourth quarter and full-year financial results for 2024. The report is available as an attachment and ...